AR046094A1 - Anticuerpos completamente humanos contra 4-1bb humano - Google Patents

Anticuerpos completamente humanos contra 4-1bb humano

Info

Publication number
AR046094A1
AR046094A1 ARP040103643A ARP040103643A AR046094A1 AR 046094 A1 AR046094 A1 AR 046094A1 AR P040103643 A ARP040103643 A AR P040103643A AR P040103643 A ARP040103643 A AR P040103643A AR 046094 A1 AR046094 A1 AR 046094A1
Authority
AR
Argentina
Prior art keywords
human
chain variable
variable region
antibody
region comprises
Prior art date
Application number
ARP040103643A
Other languages
English (en)
Spanish (es)
Inventor
Maria Jure-Kungel
Laura J Hefta
Marc Santoro
Subinay Ganguly
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37426115&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR046094(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AR046094A1 publication Critical patent/AR046094A1/es

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ARP040103643A 2003-10-10 2004-10-07 Anticuerpos completamente humanos contra 4-1bb humano AR046094A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51019303P 2003-10-10 2003-10-10

Publications (1)

Publication Number Publication Date
AR046094A1 true AR046094A1 (es) 2005-11-23

Family

ID=37426115

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040103643A AR046094A1 (es) 2003-10-10 2004-10-07 Anticuerpos completamente humanos contra 4-1bb humano

Country Status (5)

Country Link
CN (1) CN1867585B (zh)
AR (1) AR046094A1 (zh)
PE (1) PE20050962A1 (zh)
TW (1) TWI332844B (zh)
ZA (1) ZA200602834B (zh)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110357961A (zh) * 2018-04-10 2019-10-22 无锡智康弘义生物科技有限公司 抗人4-1bb单克隆抗体及其制备方法和用途
CN112010974A (zh) * 2019-05-30 2020-12-01 山东博安生物技术有限公司 一种特异性结合人4-1bb的抗体及其应用
US11555077B2 (en) 2017-11-09 2023-01-17 Shanghai Hyamab Biotech Co., Ltd. 4-1BB antibody and preparation method and use thereof
US12054554B2 (en) 2018-04-10 2024-08-06 Wuxi Biologics (Shanghai) Co., Ltd. Monoclonal antibody against human 4-1BB, method for preparing the same, and use thereof

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2710717C2 (ru) * 2010-09-09 2020-01-10 Пфайзер Инк. Молекулы, связывающиеся с 4-1ВВ
KR101503341B1 (ko) 2014-03-12 2015-03-18 국립암센터 자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법
US11008396B2 (en) * 2015-05-21 2021-05-18 Alligator Bioscience Ab Polypeptides
JP6845846B6 (ja) * 2015-09-22 2021-04-21 ディンフー バイオターゲット カンパニー リミテッド 抗ヒトｃｄ１３７の完全ヒト抗体及びその用途
GB201619648D0 (en) * 2016-11-21 2017-01-04 Alligator Bioscience Ab Novel antibodies and uses thereof
KR102089072B1 (ko) 2017-01-06 2020-03-17 주식회사 유틸렉스 항-인간 4-1bb 항체 및 그의 용도
CN116789832A (zh) * 2017-06-25 2023-09-22 西雅图免疫公司 抗4-1bb抗体及其制备和使用方法
MA49565A (fr) * 2017-07-11 2020-05-20 Compass Therapeutics Llc Anticorps agonistes qui lient cd137 humain et leurs utilisations
WO2019036855A1 (en) 2017-08-21 2019-02-28 Adagene Inc. ANTI-CD137 MOLECULES AND THEIR USE
CN109651507B (zh) 2017-10-12 2021-11-26 瑞阳(苏州)生物科技有限公司 一种激动型4-1bb单克隆抗体
WO2019072274A1 (zh) * 2017-10-12 2019-04-18 瑞阳(苏州)生物科技有限公司 一种激动型4-1bb单克隆抗体
JP2021510533A (ja) * 2018-01-22 2021-04-30 江蘇恒瑞医薬股▲ふん▼有限公司 抗４−１ｂｂ抗体、その抗原結合フラグメント、およびその医学的使用
WO2019148445A1 (en) 2018-02-02 2019-08-08 Adagene Inc. Precision/context-dependent activatable antibodies, and methods of making and using the same
CN112867733B (zh) * 2018-10-19 2023-01-06 苏州丁孚靶点生物技术有限公司 抗cd137抗体及其应用
CN111320691B (zh) * 2018-12-17 2022-04-05 程联胜 一种抗人4-1bb单克隆抗体及其应用
CN113842456B (zh) * 2020-06-28 2022-07-26 上海齐鲁制药研究中心有限公司 一种抗人4-1bb的单克隆抗体制剂及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5369996A (en) * 1995-03-23 1996-10-08 Indiana University Foundation Monoclonal antibody against human receptor protein 4-1bb and methods of its use for treatment of diseases
RU2192281C2 (ru) * 1996-10-11 2002-11-10 Бристол-Маерс Сквибб Компани Способы и композиции для иммуномодуляции

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11555077B2 (en) 2017-11-09 2023-01-17 Shanghai Hyamab Biotech Co., Ltd. 4-1BB antibody and preparation method and use thereof
CN110357961A (zh) * 2018-04-10 2019-10-22 无锡智康弘义生物科技有限公司 抗人4-1bb单克隆抗体及其制备方法和用途
CN110357961B (zh) * 2018-04-10 2022-08-23 无锡智康弘义生物科技有限公司 抗人4-1bb单克隆抗体及其制备方法和用途
US12054554B2 (en) 2018-04-10 2024-08-06 Wuxi Biologics (Shanghai) Co., Ltd. Monoclonal antibody against human 4-1BB, method for preparing the same, and use thereof
CN112010974A (zh) * 2019-05-30 2020-12-01 山东博安生物技术有限公司 一种特异性结合人4-1bb的抗体及其应用

Also Published As

Publication number Publication date
TW200517124A (en) 2005-06-01
TWI332844B (en) 2010-11-11
PE20050962A1 (es) 2005-11-17
ZA200602834B (en) 2007-07-25
CN1867585A (zh) 2006-11-22
CN1867585B (zh) 2011-02-09

Similar Documents

Publication Publication Date Title
AR046094A1 (es) Anticuerpos completamente humanos contra 4-1bb humano
ES2527961T3 (es) Anticuerpos monoclonales humanos para CD70
RS20060234A (en) Fully human antibodies against human 4-1bb (cd137)
CL2008002923A1 (es) Anticuerpo monoclonal humano aislado porque se adhiere a mesotelina humana; composicion que comprende dicho anticuerpo; conjugado entre anticuerpo y agente terapeutico; molecula de acido nucleico que codifica el anticuerpo; uso para preparar un medicamento para tratar cancer.
WO2004010947A3 (en) Humanized antibodies against human 4-1bb
GEP20074222B (en) Antibodies to cd40
ES2523194T3 (es) Anticuerpo monoclonal humano específico para cada tumor
AR050642A1 (es) Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/ calicheamicina
ES2572231T3 (es) Anticuerpos monoclonales anti-IL-21 humana
RU2011116112A (ru) Биспецифические анти-egfr/анти-igf-1r антитела
NZ594466A (en) Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
ES2572177T3 (es) Anticuerpos neutralizantes anti-B7RP1 humanos
EA202092460A1 (ru) Антитела к ox40 и способы применения
UA90457C2 (ru) Человеческое моноклональное антитело, которое специфически связывается с м-csf человека и блокирует связывание м-csf с с-fms
EA201490957A1 (ru) Лечение гематологических злокачественных заболеваний с помощью анти-cxcr4 антитела
PE20120079A1 (es) Moleculas de anticuerpos mejoradas
UA89350C2 (uk) Гуманізоване антитіло, що зв'язує людський cd20
PE20120014A1 (es) Anticuerpos humanos de alta afinidad contra pcsk9
NO20026063D0 (no) Antistoffer mot human MCP-1
ECSP066432A (es) Moléculas de enlace terapéuticas
NZ599196A (en) Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
WO2011051327A3 (en) Small antibody-like single chain proteins
PE20061166A1 (es) Moleculas de anticuerpo que tienen especificidad para la il-17 humana
PE20080214A1 (es) Moleculas de anticuerpo que se unen a la il-17 humana
DK1684869T3 (da) Fremgangsmåde til terapi af B-celle-relaterede cancersygdomme

Legal Events

Date Code Title Description
FG Grant; registration